Thoracic staging with (18)F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to (18)F-FDG PET/CT?
2017
Objective
To investigate whether differences in thoracic tumour staging between 18F-FDG PET/CT and PET/MR imaging lead to different therapeutic decisions in Non-Small Cell Lung Cancer (NSCLC).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
36
Citations
NaN
KQI